Recall
FDAHealthJune 20, 2025

ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharma

⚠️ Subpotent Drug: Assay below the approved specification

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 20, 2025

Nationwide in the USA

What's affected?

Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-456-17
UPC
0316729447157
Lot code
D2300042

Additional details

Lot #D2300042, Exp Date: 12/31/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 2,344 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.